Subject Area and Research Team: IX. Cancer prevention and early detection
Research topics
1. Identification and characterization of cancer environmental risk factors
2. Application of modern imaging methods in early diagnostics of precancerous conditions and malignancy (narrow band imagining, videodermoscopy, confocal microscopy)
3. Studies on genetic cancer predisposition
Key current projects
1. Validation of multiparametric models and circulating and imaging biomarkers to improve lung cancer early detection of smoking cessation after diagnosis of cancer
2. Testis microlithasis as precancerous lesions in the development of germ cell tumours in children
3. Identification of new dermoscopic markers and their utility in primary and secondary skin cancer prevention
4. Exposure to endocrine disrupting chemicals and the risk of hormone dependent cancers
Coordinators
| Coordinator #1 | Coordinator #2 | Coordinator #3 | |
|---|---|---|---|
| Name and surname |  |
 |
 |
| Academic degree | Dr. Habil. | Dr. Habil. | Dr. Habil., Assoc. Prof. |
| Employment unit | Department of Dermatology, Venereology and Allergology | Department of Otolaryngology | Division of Public Health & Social Medicine |
| Polish Platform of Medical Research | Dr. Habil. Michał Sobjanek | Dr. Habil. Bogusław Mikaszewski | Dr. Habil. Łukasz Balwicki, Assoc. Prof. |
| michal.sobjanek@gumed.edu.pl | boguslaw.mikaszewski@gumed.edu.pl | lukasz.balwicki@gumed.edu.pl | |
| Phone number | +48 58 349 40 10 | +48 58 349 31 10 | +48 58 349 25 40 |
photos Paweł Sudara/MUG, Sylwia Mierzewska/UCC
Research Team: IX. Cancer prevention and early detection
Team Members: IX. Cancer prevention and early detection (163 KB)Feel free to contact one of our coordinators to join our Research Team.
Key grants
| Funding agency/grant number | Title of the project | Years | |
|---|---|---|---|
| 1. | National Science Centre | Radiomic and metabolomic signatures of early lung cancer | 2018-2021 |
| 2. | „Horizon 2020 – the Framework Programme for Research and Innovation” ERA-NET TRANSCAN/01/2019. | Validation of multiparametric models and circulating and imaging biomarkers to improve lung cancer early detection | 2014-2020 |
International cooperation
| Foreign partner (unit name) | Principal investigator(s) | Area of cooperation | |
|---|---|---|---|
| 1. | International Association for the Study of Lung Cancer (IASLC) | Ugo Pastorino | Diagnostics and treatment of early lung cancer, lung cancer screening |
| 2. | Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy | Barbara Alicja Jereczek-Fossa | Signalling pathways in head and neck cancer |
| 3. | Aristotle University, Thessaloniki, Greece | Aimilios Lallas | Mucoscopy as an emerging tool in the diagnostics of oral pathology |
Key publications
1. Rzyman W, Szurowska E, Adamek M. Implementation of Lung Cancer Screening at The National Level: Polish Example. Transl Lung Cancer Res 2019; vol. 8: p. 95-105.
2. Pedersen J, Rzyman W, Veronsei G, D’amico T, Van Schil P, Molins L, Massard G Et al. Recommendations from The European Society of Thoracic Surgeons (Ests) Regarding Computed Tomography Screening for Lung Cancer In Europe. Eur J Cardio-Thorac Surg 2017; vol. 51: p. 411-420.
3. Ros-Mazurczyk M, Jelonek K, Marczyk M, Binczyk F, Pietrowska M, Polanska J, Dziadziuszko R, Jassem J, Rzyman W, Widlak P. Serum lipid profile discriminates patients with early lung cancer from healthy controls. Lung Cancer. 2017; vol. 112: p. 69-74.
4. Widlak P, Pietrowska M, Polanska J, Marczyk M, Ros-Mazurczyk M, Dziadziuszko R, Jassem J, Rzyman W. Serum mass profile signature as a biomarker of early lung cancer. Lung Cancer. 2016; vol. 99: p. 46-52.
5. Sławińska M, Zabłotna M, Gleń J, Lakomy J, Nowicki RJ, Sobjanek M. STAT3 polymorphisms and IL-6 polymorphism are associated with the risk of basal cell carcinoma in patients from northern Poland. Arch Dermatol Res. 2019; vol. 311: p. 697-704.